1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    







































































































































    Armies of Pestilence: CNS Infections as Potential Weapons of Mass Destruction | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Review ArticleReview Articles

  
      
Open Access

  
      
Armies of Pestilence: CNS Infections as Potential Weapons of Mass Destruction
  
    	
B.L. Hart and L. Ketai

  
    	
American Journal of Neuroradiology June 2015,  36 (6) 1018-1025; DOI: https://doi.org/10.3174/ajnr.A4177 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵
    1. Dembek  ZF
    1. 

    2. Martin  JW, 
    3. Christopher  GW, 
    4. Eitzen  EM
    . History of biological weapons: from poisoned darts to intentional epidemics. In: Dembek  ZF, ed. Medical Aspects of Biological Warfare. Washington, DC: Borden Institute; 2007:1–20
  2. 2.↵
    1. 

    2. Croddy  E
    . Chemical and Biological Warfare: A Comprehensive Survey for the Concerned Citizen. New York: Copernicus Books; 2002
  3. 3.↵
    1. 

    2. Manchee  RJ, 
    3. Broster  MG, 
    4. Stagg  AJ, et al
    . Formaldehyde solution effectively inactivates spores of Bacillus anthracis on the Scottish island of Gruinard. Appl Environ Microbiol 1994;60:4167–71
    Abstract/FREE Full Text
  4. 4.↵
    1. 

    2. Cook  MS, 
    3. Woolf  AF
    . Preventing proliferation of biological weapons: US assistance to the former Soviet states. Published April 10, 2002. http://oai.dtic.mil/oai/oai?verb=getRecord&metadataPrefix=html&identifier=ADA454722. Accessed August 1, 2014. 
  5. 5.↵
    PBS: American Experience. The Living Weapon. http://www.pbs.org/wgbh/americanexperience/features/transcript/weapon-transcript/. Accessed August 1, 2014. 
  6. 6.↵
    1. 

    2. Meselson  M, 
    3. Guillemin  J, 
    4. Hugh-Jones  M, et al
    . The Sverdlovsk anthrax outbreak of 1979. Science 1994;266:1202–08
    Abstract/FREE Full Text
  7. 7.↵
    1. 

    2. Abramova  FA, 
    3. Grinberg  LM, 
    4. Yampolskaya  OV, et al
    . Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A 1993;90:2291–94
    Abstract/FREE Full Text
  8. 8.↵
    1. 

    2. Ragg  V
    . Russia: anthrax in the Urals. Lancet 1992;339:419–20
    PubMed
  9. 9.↵
    1. 

    2. Takahashi  H, 
    3. Keim  P, 
    4. Kaufmann  AF, et al
    . Bacillus anthracis bioterrorism incident, Kameido, Tokyo, 1993. Emerg Infect Dis 2004;10:117–20
    CrossRefPubMed
  10. 10.↵
    1. 

    2. Jernigan  JA, 
    3. Stephens  DS, 
    4. Ashford  DA, et al
    . Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933–44
    CrossRefPubMedWeb of Science
  11. 11.↵
    1. 

    2. Jernigan  DB, 
    3. Raghunathan  PL, 
    4. Bell  BP, et al
    . Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002;8:1019–28
    CrossRefPubMedWeb of Science
  12. 12.↵
    1. 

    2. Dixon  TC, 
    3. Meselson  M, 
    4. Guillemin  J, et al
    . Anthrax. N Engl J Med 1999;341:815–26
    CrossRefPubMedWeb of Science
  13. 13.↵
    1. Dembek  ZF
    1. 

    2. Purcell  BK, 
    3. Worsham  PL, 
    4. Friedlander  AM
    . Anthrax. In: Dembek  ZF, ed. Medical Aspects of Biological Warfare. Washington, DC: Borden Institute; 2007:69–90
  14. 14.↵
    1. 

    2. Ramsay  CN, 
    3. Stirling  A, 
    4. Smith  J, et al
    . An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Euro Surveill 2010;15:pii:19465
  15. 15.↵
    1. 

    2. Palmateer  NE, 
    3. Ramsay  CN, 
    4. Browning  L, et al
    . Anthrax infection among heroin users in Scotland during 2009–2010: a case-control study by linkage to a national drug treatment database. Clin Infect Dis 2012;55:706–10
    Abstract/FREE Full Text
  16. 16.↵
    1. 

    2. Abbara  A, 
    3. Brooks  T, 
    4. Taylor  GP, et al
    . Lessons for control of heroin-associated anthrax in Europe from 2009–2010 Outbreak Case Studies, London, UK. Emerg Infect Dis 2014;20:1115–22
    PubMed
  17. 17.↵
    1. 

    2. Brachman  PS
    . Inhalation anthrax. Ann N Y Acad Sci 1980;353:83–93
    CrossRefPubMed
  18. 18.↵
    1. 

    2. Ketai  L, 
    3. Alrahji  AA, 
    4. Hart  B, et al
    . Radiologic manifestations of potential bioterrorist agents of infection. AJR Am J Roentgenol 2003;180:565–75
    CrossRefPubMedWeb of Science
  19. 19.↵
    National Services Scotland on behalf of the National Anthrax Outbreak Control Team. An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010. 
December 2011. http://www.documents.hps.scot.nhs.uk/giz/anthrax-outbreak/anthrax-outbreak-report-2011-12.pdf. Accessed April 2, 2014. 
  20. 20.↵
    1. 

    2. Tahernia  AC, 
    3. Hashemi  G
    . Survival in anthrax meningitis. Pediatrics 1972;50:329–33
    Abstract/FREE Full Text
  21. 21.↵
    1. 

    2. Kim  HJ, 
    3. Jun  WB, 
    4. Lee  SH, et al
    . CT and MR findings of anthrax meningoencephalitis: report of two cases and review of the literature. AJNR Am J Neuroradiol 2001;22:1303–05
    Abstract/FREE Full Text
  22. 22.↵
    1. 

    2. Yildirim  H, 
    3. Kabakus  N, 
    4. Koc  M, et al
    . Meningoencephalitis due to anthrax: CT and MR findings. Pediatr Radiol 2006;36:1190–93
    CrossRefPubMed
  23. 23.↵
    1. 

    2. Booth  MG, 
    3. Hood  J, 
    4. Brooks  TJ, et al
    . Anthrax infection in drug users. Lancet 2010;375:1345–46
    PubMedWeb of Science
  24. 24.↵
    1. 

    2. Hendricks  KA, 
    3. Wright  ME, 
    4. Shadomy  SV, et al
    . Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis 2014;20 doi: 10.3201/eid2002.130687. 
  25. 25.↵
    1. 

    2. Tucker  JB
    . Scourge: The Once and Future Threat of Smallpox. New York: Atlantic Monthly Press; 2001
  26. 26.↵
    1. 

    2. Inglesby  TV, 
    3. Dennis  DT, 
    4. Henderson  DA, et al
    . Plague as a biological weapon: medical and public health management—Working Group on Civilian Biodefense. JAMA 2000;283:2281–90
    CrossRefPubMedWeb of Science
  27. 27.↵
    1. 

    2. Bray  RS
    . Armies of Pestilence: The Impact of Disease on History. Cambridege: James Clarke and Co; 2004
  28. 28.↵
    1. 

    2. Becker  TM, 
    3. Poland  JD, 
    4. Quan  TJ, et al
    . Plague meningitis: a retrospective analysis of cases reported in the United States, 1970–1979. West J Med 1987;147:554–57
    PubMedWeb of Science
  29. 29.↵
    1. 

    2. Martin  AR, 
    3. Hurtado  FP, 
    4. Plessala  RA, et al
    . Plague meningitis: a report of three cases in children and review of the problem. Pediatrics 1967;40:610–16
    Abstract/FREE Full Text
  30. 30.↵
    1. 

    2. Jawetz  E, 
    3. Meyer  KF
    . The behaviour of virulent and avirulent P. pestis in normal and immune experimental animals. J Infect Dis 1944;74:1–13
    FREE Full Text
  31. 31.↵
    1. 

    2. Hofinger  DM, 
    3. Cardona  L, 
    4. Mertz  GJ, et al
    . Tularemic meningitis in the United States. Arch Neurol 2009;66:523–27
    CrossRefPubMed
  32. 32.↵
    1. 

    2. Lovell  VM, 
    3. Cho  CT, 
    4. Lindsey  NJ, et al
    . Francisella tularensis meningitis: a rare clinical entity. J Infect Dis 1986;154:916–18
    FREE Full Text
  33. 33.↵
    1. 

    2. van de Beek  D, 
    3. Steckelberg  JM, 
    4. Marshall  WF, et al
    . Tularemia with brain abscesses. Neurology 2007;68:531–31
    CrossRef
  34. 34.↵
    1. 

    2. Anderson  A, 
    3. Bijlmer  H, 
    4. Fournier  PE, et al
    . Diagnosis and management of Q fever–United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep 2013;62(RR-03):1–30
    PubMed
  35. 35.↵
    1. 

    2. Schattner  A, 
    3. Kushnir  M, 
    4. Zhornicky  T, et al
    . Lymphocytic meningitis as the sole manifestation of Q fever. Postgrad Med J 1993;69:636–37
    Abstract/FREE Full Text
  36. 36.↵
    1. 

    2. Kofteridis  DP, 
    3. Mazokopakis  EE, 
    4. Tselentis  Y, et al
    . Neurological complications of acute Q fever infection. Eur J Epidemiol 2004;19:1051–54
    CrossRefPubMedWeb of Science
  37. 37.↵
    1. 

    2. Bernit  E, 
    3. Pouget  J, 
    4. Janbon  F, et al
    . Neurological involvement in acute Q fever: a report of 29 cases and review of the literature. Arch Intern Med 2002;162:693–700
    CrossRefPubMedWeb of Science
  38. 38.↵
    1. 

    2. Pappas  G, 
    3. Akritidis  N, 
    4. Bosilkovski  M, et al
    . Brucellosis. N Engl J Med 2005;352:2325–36
    CrossRefPubMedWeb of Science
  39. 39.↵
    1. Dembek  ZF
    1. 

    2. Purcell  BK, 
    3. Hoover  DL, 
    4. Friedlander  AM
    . Brucellosis. In: Dembek  ZF, ed. Medical Aspects of Biological Warfare. Washington, DC: Borden Institute; 2007:185–98
  40. 40.↵
    1. 

    2. Bilen  Ş, 
    3. Güneş  HN, 
    4. Saka  M, et al
    . Four different clinical manifestations of neurobrucellosis (case reports). Eur J Intern Med 2008;19:e75–e77
    CrossRefPubMed
  41. 41.↵
    1. 

    2. Al-Sous  MW, 
    3. Bohlega  S, 
    4. Al-Kawi  MZ, et al
    . Neurobrucellosis: clinical and neuroimaging correlation. AJNR Am J Neuroradiol 2004;25:395–401
    Abstract/FREE Full Text
  42. 42.↵
    1. 

    2. Bossi  P, 
    3. Tegnell  A, 
    4. Baka  A, et al
    . BICHAT guidelines for the clinical management of viral encephalitis and bioterrorism-related viral encephalitis. Euro Surveill 2004;9:E21–22
    PubMed
  43. 43.↵
    1. 

    2. Misra  UK, 
    3. Kalita  J
    . Overview: Japanese encephalitis. Prog Neurobiol 2010;91:108–20
    CrossRefPubMed
  44. 44.↵
    1. 

    2. Kalita  J, 
    3. Misra  UK, 
    4. Pandey  S, et al
    . A comparison of clinical and radiological findings in adults and children with Japanese encephalitis. Arch Neurol 2003;60:1760–64
    CrossRefPubMedWeb of Science
  45. 45.↵
    1. 

    2. Kalita  J, 
    3. Misra  UK
    . Comparison of CT scan and MRI findings in the diagnosis of Japanese encephalitis. J Neurol Sci 2000;174:3–8
    CrossRefPubMedWeb of Science
  46. 46.↵
    1. 

    2. Ali  M, 
    3. Safriel  Y, 
    4. Sohi  J, et al
    . West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol 2005;26:289–97
    Abstract/FREE Full Text
  47. 47.↵
    1. 

    2. Leis  AA, 
    3. Stokic  DS, 
    4. Polk  JL, et al
    . A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med 2002;347:1279–80
    CrossRefPubMedWeb of Science
  48. 48.↵
    1. 

    2. Sejvar  JJ, 
    3. Leis  AA, 
    4. Stokic  DS, et al
    . Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 2003;9:788–93
    CrossRefPubMedWeb of Science
  49. 49.↵
    1. Dembek  ZF
    1. 

    2. Steele  KE, 
    3. Reed  DS, 
    4. Glass  PJ, et al
    . Alphavirus encephalitides. In: Dembek  ZF, ed. Medical Aspects of Biological Warfare. Washington, DC: Borden Institute; 2007:241–70
  50. 50.↵
    1. 

    2. Deresiewicz  RL, 
    3. Thaler  SJ, 
    4. Hsu  L, et al
    . Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med 1997;336:1867–74
    CrossRefPubMedWeb of Science
  51. 51.↵
    1. 

    2. Lury  K, 
    3. Castillo  M
    . Eastern equine encephalitis: CT and MRI findings in one case. Emerg Radiol 2004;11:46–48
    PubMed
  52. 52.↵
    1. 

    2. Silverman  MA, 
    3. Misasi  J, 
    4. Smole  S, et al
    . Eastern equine encephalitis in children, Massachusetts and New Hampshire USA, 1970–2010. Emerg Infect Dis 2013;19:194–201
    CrossRefPubMed
  53. 53.↵
    1. 

    2. Alrajhi  AA, 
    3. Al-Semari  A, 
    4. Al-Watban  J
    . Rift Valley fever encephalitis. Emerg Infect Dis 2004;10:554–55
    CrossRefPubMedWeb of Science
  54. 54.↵
    1. 

    2. Carod-Artal  FJ, 
    3. Wichmann  O, 
    4. Farrar  J, et al
    . Neurological complications of dengue virus infection. Lancet Neurol 2013;12:906–19
    CrossRefPubMed
  55. 55.↵
    1. 

    2. Bhoi  SK, 
    3. Naik  S, 
    4. Kumar  S, et al
    . Cranial imaging findings in dengue virus infection. J Neurol Sci 2014;342:36–41
    CrossRefPubMed
  56. 56.↵
    1. 

    2. Cam  BV, 
    3. Fonsmark  L, 
    4. Hue  NB, et al
    . Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg 2001;65:848–51
    Abstract
  57. 57.↵
    1. 

    2. Chua  KB
    . Nipah virus: a recently emergent deadly paramyxovirus. Science 2000;288:1432–35
    Abstract/FREE Full Text
  58. 58.↵
    1. 

    2. Luby  SP, 
    3. Gurley  ES, 
    4. Hossain  MJ
    . Transmission of human infection with Nipah virus. Clin Infect Dis 2009;49:1743–48
    Abstract/FREE Full Text
  59. 59.↵
    1. 

    2. Lim  CCT, 
    3. Lee  WL, 
    4. Leo  YS, et al
    . Late clinical and magnetic resonance imaging follow up of Nipah virus infection. J Neurol Neurosurg Psychiatry 2003;74:131–33
    Abstract/FREE Full Text
  60. 60.↵
    1. 

    2. Sarji  SA, 
    3. Abdullah  BJ, 
    4. Goh  KJ, et al
    . MR imaging features of Nipah encephalitis. AJR Am J Roentgenol 2000;175:437–42
    CrossRefPubMedWeb of Science
  61. 61.↵
    1. 

    2. Morens  DM, 
    3. Fauci  AS
    . Chikungunya at the door: déjà vu all over again? N Engl J Med 2014;371:885–87
    CrossRefPubMedWeb of Science
  62. 62.↵
    1. 

    2. Burt  FJ, 
    3. Rolph  MS, 
    4. Rulli  NE, et al
    . Chikungunya: a re-emerging virus. Lancet 2012;379:662–71
    CrossRefPubMedWeb of Science
  63. 63.↵
    1. 

    2. Economopoulou  A, 
    3. Dominguez  M, 
    4. Helynck  B, et al
    . Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Réunion. Epidemiol Infect 2009;137:534–41
    CrossRefPubMedWeb of Science
  64. 64.↵
    1. 

    2. Gérardin  P, 
    3. Barau  G, 
    4. Michault  A, et al
    . Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion. PLoS Med 2008;5:e60
    CrossRefPubMed
  65. 65.↵
    1. Dembek  ZF
    1. 

    2. Whitehouse  CA, 
    3. Schmaljohn  AL, 
    4. Dembek  ZF
    . Emerging infectious diseases and future threats. In: Dembek  ZF, ed. Medical Aspects of Biological Warfare. Washington, DC: Borden Institute; 2007:579–607
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Armies of Pestilence: CNS Infections as Potential Weapons of Mass Destruction
  
    	
B.L. Hart, L. Ketai

  
    	
 American Journal of Neuroradiology Jun 2015, 36 (6) 1018-1025; DOI: 10.3174/ajnr.A4177 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    

  

    
 Related Articles
  • No related articles found.
 Cited By...
  • No citing articles found.
 More in this TOC Section
 Similar Articles

  



  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement